Thomas R. Kuhn - Jan 22, 2025 Form 4 Insider Report for Anterix Inc. (ATEX)

Role
Director, Chairman
Signature
s/ Gena L. Ashe, Attorney-in-Fact
Stock symbol
ATEX
Transactions as of
Jan 22, 2025
Transactions value $
$0
Form type
4
Date filed
1/24/2025, 05:24 PM
Previous filing
Jan 14, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATEX Stock Option (Right to Buy) Award $0 +56.8K $0.00 56.8K Jan 22, 2025 Common Stock 56.8K $29.84 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shares shall vest in full and become exercisable on January 22, 2028, subject to the Reporting Person's continued service with the Issuer through this date.